Диссертация (1139465), страница 56
Текст из файла (страница 56)
8. – P. 1.188. Clinical presentation of tuberculosis in culture-positive children. Pediatric Tuberculosis Consortium / M. Burroughs[ et al.] // Pediatr. Infect. Dis. J. –1999. – Vol. 18, № 5. – P. 440–446.334189. Clinical features and outcome in children admitted to a TB hospital inthe Western Cape-the influence of HIV infection and drug resistance / M.
Soeters[et al.] // South African Med. J. – 2005. – Vol. 95, № 8. – P. 602-606.190. Community-based therapy for multidrug- resistant tuberculosis in Lima, Peru / C. Mitnick [et al.] // N. Engl. J. Med. - 2003. – Vol. 348. – P. 119-128.191. Comparison of a whole-blood interferon gamma assay with tuberculinskin testing for detecting latent Mycobacterium tuberculosis infection / G.H. Mazurek [et al.] // J. Am. Med. Assoc. – 2001. – Vol. 286, № 14. – P.
1740-1747.192. Complications of BCG vaccination in HIV-infected and -uninfectedchildren: (Children with HIV Early Antiretroviral Therapy) CHER study / H. Rabie [et al.]. // 15th Conference on Retroviruses and Opportunistic Infections. - Boston, MA, USA: CHER, 2008.193. Comstock, G.W. Long-term results of BCG vaccination in the southern United States / G.W.
Comstock, C.E. Palmer //Am. Rev. Respir. Dis. – 1966. Vol. 93. –P. 171-183.194. Consensus statement on the revised World Health Organization recommendations for BCG vaccination in HIV-infected infants / A. C. Hesseling [etal.] : Submitted on behalf of the BCG Working Group, Child Lung Health Section,Inter national Union Against Tuberculosis and Lung Disease, 38th Union WorldConference on Lung Health, Cape Town, 8–12 November, 2007 // Int. J. Tuberc.Lung.
Dis. - 2008. – Vol. 12. – P. 1376–1379.195. Consensus statement. Global burden of tuberculosis: estimated incidence, prevalence, and mortality by country. WHO Global Surveillance and Monitoring Project / C. Dye [et al.] // JAMA. – 1999. – Vol.
282. – P. 677-686.196. Correlation Comparative evaluation of low-molecular-mass T-cell antigens from Mycobacterium tuberculosis of ESAT-6-spesific gamma interferonproduction with pathology in cattle following Mycobacterium bovis BCG vaccina-335tion against experimental bovine tuberculosis / H. Vordermeier [et al.] // Infect.Immun. - 2002. - Vol. 70. - P. 3026-3032.197. CT scanning for the detection of tuberculosis mediatinal and hilarlymphadenopathy in children / S.
Andronicou [et al.] // Pediatric Radiology.-2004.- Vol. 34, № 3. - P. 232-236.198. Culture confirmed childhood tuberculosis in Cape Town, South Africa: a review of 596 cases / H.S. Schaaf [et al.] // BMC Infect. Dis. - 2007. - № 7. –P. 140.199. Culture positive tuberculosis in human immunodeficiency virus type1-infected children / H.S. Schaaf [et al.] // Pediatr. Infect. Dis. J. - 1998. – Vol. 17,№7.
– P. 599-604.200. De-Castro-Toledo, A.-C. Risk factors for tuberculosis among humanimmunodeficiency virus-infected persons. A case- control study in Belo Horizonte,Minas Gerais, Brazil (1985-1996) / A.-C. De-Castro-Toledo, D.-B. Greco, C.-M.Antunes // Mem.-Inst.- Oswaldo-Cruz. – 2000, Jul-Aug. –Vol. 95, № 4. – P. 437443.201. Determining causes of mortality in children enrolled in a vaccine fieldtrial in a rural area in the Western Cape Province of South Africa / S. Moyo [et al.]// J. Paediatr.
Child. Health. – 2007. – Vol. 43. – P. 178–183.202. Diagnosed tuberculosis during the follow-up of a cohort of humanimmunodeficiency virus infected children in Abidjan, Cote d’Ivoire: ANRS 1278study / N. Elenga [ et al.] // Pediatr. Infect. Dis. J. – 2005. – Vol. 24, № 12. – P.1077-1082.203. Diagnosis of pediatric tuberculosis in the modern era / N. Neu [et al.]// Pediatr. Infect. Dis. J. – 1999. – Vol. 18, № 2. – P.
122-126.204. Diagnosis of tuberculosis in South African children with a T-cellbased assay: a prospective cohort study / S. Liebeschuetz [et al.] // Lancet. – 2004.- Vol. 364(9452). – P. 2196-2203.336205. Diagnostic and Management Challenges for Childhood Tuberculosisin the Era of HIV / B.J. Marais [et al.] // J. Infect.
Dis. – 2007. - Vol. 196, Supplement 1. – S. 76-85.206. Duration of efficacy of treatment of latent tuberculosis infection inHIV-infected adults / J.L. Johnson [et al.] // AIDS. – 2001. – Vol. 15. – P. 21372147.207. Early antiretroviral therapy and mortality among HIV-infected infants/ A.
Violari [et al.] // N. Engl. J. Med. – 2008. – Vol. 359. – P. 2233–2244.208. Effect of isoniazid prophylaxis on incidence of active tuberculosis andprogression of HIV infection / J.W. Pape [et al.] // Lancet. – 1993. –Vol. 342. – P.268-272.209. Effect of isoniazid prophylaxis on mortality and incidence of tuberculosis in children with HIV: randomized controlled trial / H.J. Zar [et al.] // BritishMed. J. - 2007. – Vol.
334. – P. 136.210. Effect of Mycobacterium tuberculosis on HIV replication. Role ofimmune activation / D. Goletti [et al.] // J. Immunol. – 1996. – Vol. 157, № 3. – P.1271-1278.211. Effect of routine isoniazid preventive therapy on tuberculosis incidence among HIV-infected men in South Africa: a novel randomized incrementalrecruitment study / A.D. Grant [et al.] // JAMA. – 2005. – Vol.
293. – P. 27192725.212.Efficacy of secondary isoniazid preventive therapy among HIV-infected Southern Africans: time to change policy / G.J. Churchyard [et al.] //AIDS. – 2003. – Vol. 17. – P. 2063-2070.213. Epidemiology of tuberculosis among children in the United States:1985 to 1994 / X.
Ussery [et al.] // Pediatr. Infect. Dis. – 1996. - № 15. – P. 697–704.337214. European framework to decrease the burden of TB/HIV. - WHO Regional Office for Europe, 2003, 5 May. - 340 р.215. Fatal and severe hepatitis associated with rifampin and pyrazinamidefor the treatment of latent tuberculosis infection / Centers for Disease Control andPrevention. // MMWR. – 2001. - Vol. 50, № 15.
– P. 735-738.216. Ferebee, S. Prophylactic effects of isoniazid of primary tuberculosis inchildren / S. Ferebee, F.W. Mount, A.A.Anastasiades // Am. Rev. Tuberc. - 1957.– Vol. 76, № 6. - P. 942 - 963.217. Generalized tuberculosis in the acquired immune deficiency syndrome/ M.-B. Smith [et al.] //Arch.-Pathol.-Lab.-Med. — 2000, Sep. - Vol. 124, № 9. - P.267-274.218. Global tuberculosis report 2013, WHO/HTM/TB/2013.11.219. Global Advisory Committee on Vaccine Safety, 12-13 June 2007 //Wkly Epidemiologic Rec.
– 2007, Jul. 20. – Vol. 82, № 28/29. – P. 252-259220. Global Advisory Committee on Vaccine Safety, World Health Organization. Revised BCG vaccination guidelines for infants at risk for HIV infection //Wkly Epidemiologic Rec . – 2007. – Vol. 82. – P. 193– 196.221. Graham, S.M. Pulmonary disease in HIV-infected African children /S.M. Graham, J.B. Coulter, C.F. Gilks // Int. J. of Tuberc.
and Lung Dis. – 2001. –Vol. 5, № 1. – P. 12-23.222. Harries, A-D. An approach to the problems of diagnosing and. treatingadult smear negative pulmonary tuberculosis in high-HTV prevalence settings insub Saharan Africa / A-D. Harries, D. Mäher, P. Nunn // Bull.-World-HealthOrgan. - 1998. –Vol. 76, № 6. - P. 651-662.223. Harrington, M. World AIDS Series: Hit HIV-1 hard, but only whennecessary / M. Harrington, C.J.
Carpenter // Lancet. – 2000. – Vol. 355. – P. 21472152.338224. Havlir, D.V. Tuberculosis in patients with human immunodeficiencyvirus infection / D.V. Havlir, R.E. Barnes // New Engl. J. Med. – 1999. -Vol. 340,№ 5. – P. 367-73.225. High incidence of tuberculosis among HIV-infected infants: evidencefrom a South African population based study highlights the need for improved tuberculosis control strategies / A.C. Hesseling [et al.] // Clin. Infect. Dis.
– 2009. –Vol. 48. – P. 108–114.226. HIV-1 co infection in children hospitalized with tuberculosis in SouthAfrica / S.A. Madhi [et al.] // Int. J. of Tuberculosis and Lung Disease. – 2000. Vol. 4, № 5. – S. 448-454.227. HIV-associated tuberculosis in the era of highly active antiretroviraltherapy. The Adult/Adolescent Spectrum of HIV Disease Group / J.L.
Jones [et al.]// Int. J. Tuberc. Lung. Dis. – 2000. - № 4. – P. 1026-1031.228. HIV-associated tuberculosis in the era of highly active antiretroviraltherapy. The Adult/Adolescent Spectrum of HIV Disease Group / J.L. Jones // Int.J. Tuberc. Lung. Dis. – 2000. – Vol. 4, № 11. – P. 1026-31.229. Hospital outbreak of multidrug-resistant Mycobacterium tuberculosisinfections: factors in transmission to staff and HIV-infected patients / C. Dooley[ etal.] / C. Beck // JAMA. – 1992.
![](https://s.studizba.com/z.php?f=/templates/si/i/noavatar.png&w=100&h=100&t=1"){kind=avatar}
